ptc-209 has been researched along with palbociclib* in 1 studies
1 other study(ies) available for ptc-209 and palbociclib
Article | Year |
---|---|
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Heterocyclic Compounds, 2-Ring; Humans; Mitogen-Activated Protein Kinase 7; Piperazines; Protein Kinase Inhibitors; Pyridines; Thiazoles | 2019 |